Track topics on Twitter Track topics that are important to you
Update: Erytech has upgraded its projected IPO to $125M by offering more shares than originally planned. Originally published 09/10/2017 Erytech has filed for an IPO on the Nasdaq Global Market and a private placement on Euronext Paris while preparing for ...
This awesome article Update: French Red Blood Cell Biotech Aims Higher for $125M Nasdaq IPO appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Update: French Red Blood Cell Biotech Aims Higher for $125M Nasdaq IPONEXT ARTICLE